| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cysteine-type deubiquitinase activity | 1.05e-07 | 114 | 21 | 5 | GO:0004843 | |
| GeneOntologyMolecularFunction | deubiquitinase activity | 1.60e-07 | 124 | 21 | 5 | GO:0101005 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein peptidase activity | 2.63e-07 | 137 | 21 | 5 | GO:0019783 | |
| GeneOntologyMolecularFunction | cysteine-type peptidase activity | 1.40e-06 | 192 | 21 | 5 | GO:0008234 | |
| GeneOntologyMolecularFunction | peptidase activity | 3.05e-06 | 654 | 21 | 7 | GO:0008233 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 9.64e-04 | 188 | 21 | 3 | GO:0005201 | |
| GeneOntologyMolecularFunction | intramembrane lipid transporter activity | 1.30e-03 | 51 | 21 | 2 | GO:0140303 | |
| GeneOntologyMolecularFunction | phospholipid transporter activity | 2.72e-03 | 74 | 21 | 2 | GO:0005548 | |
| GeneOntologyMolecularFunction | collagen binding | 3.25e-03 | 81 | 21 | 2 | GO:0005518 | |
| GeneOntologyBiologicalProcess | protein deubiquitination | 1.42e-07 | 125 | 21 | 5 | GO:0016579 | |
| GeneOntologyBiologicalProcess | protein modification by small protein removal | 2.88e-07 | 144 | 21 | 5 | GO:0070646 | |
| GeneOntologyBiologicalProcess | protein modification by small protein conjugation or removal | 4.17e-05 | 1009 | 21 | 7 | GO:0070647 | |
| GeneOntologyBiologicalProcess | post-translational protein modification | 6.21e-05 | 1074 | 21 | 7 | GO:0043687 | |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | 1.84e-04 | 1293 | 21 | 7 | GO:0005789 | |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | 1.89e-04 | 1299 | 21 | 7 | GO:0098827 | |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | 2.16e-04 | 1327 | 21 | 7 | GO:0042175 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | 1.73e-03 | 530 | 21 | 4 | GO:0062023 | |
| GeneOntologyCellularComponent | extracellular matrix | 3.76e-03 | 656 | 21 | 4 | GO:0031012 | |
| GeneOntologyCellularComponent | external encapsulating structure | 3.80e-03 | 658 | 21 | 4 | GO:0030312 | |
| MousePheno | abnormal pelvic girdle bone morphology | 1.00e-04 | 87 | 15 | 3 | MP:0004509 | |
| MousePheno | abnormal forelimb stylopod morphology | 1.19e-04 | 92 | 15 | 3 | MP:0003854 | |
| MousePheno | abnormal humerus morphology | 1.19e-04 | 92 | 15 | 3 | MP:0005296 | |
| MousePheno | thrombocytopenia | 1.64e-04 | 273 | 15 | 4 | MP:0003179 | |
| MousePheno | decreased myeloid cell number | 2.31e-04 | 567 | 15 | 5 | MP:0013662 | |
| MousePheno | abnormal pubis morphology | 2.45e-04 | 22 | 15 | 2 | MP:0004506 | |
| MousePheno | abnormal circulating alkaline phosphatase level | 4.02e-04 | 639 | 15 | 5 | MP:0000202 | |
| Domain | UCH | 1.34e-08 | 71 | 21 | 5 | PF00443 | |
| Domain | USP_2 | 1.34e-08 | 71 | 21 | 5 | PS00973 | |
| Domain | USP_3 | 1.43e-08 | 72 | 21 | 5 | PS50235 | |
| Domain | USP_dom | 1.43e-08 | 72 | 21 | 5 | IPR028889 | |
| Domain | Peptidase_C19_UCH | 1.43e-08 | 72 | 21 | 5 | IPR001394 | |
| Domain | USP_CS | 8.13e-07 | 66 | 21 | 4 | IPR018200 | |
| Domain | USP_1 | 1.03e-06 | 70 | 21 | 4 | PS00972 | |
| Domain | TIL | 7.89e-05 | 12 | 21 | 2 | PF01826 | |
| Domain | C8 | 7.89e-05 | 12 | 21 | 2 | PF08742 | |
| Domain | Unchr_dom_Cys-rich | 9.32e-05 | 13 | 21 | 2 | IPR014853 | |
| Domain | C8 | 9.32e-05 | 13 | 21 | 2 | SM00832 | |
| Domain | TIL_dom | 1.09e-04 | 14 | 21 | 2 | IPR002919 | |
| Domain | VWFD | 1.43e-04 | 16 | 21 | 2 | PS51233 | |
| Domain | HABP4_PAI-RBP1 | 1.43e-04 | 16 | 21 | 2 | PF04774 | |
| Domain | VWD | 1.43e-04 | 16 | 21 | 2 | SM00216 | |
| Domain | HABP4_PAIRBP1-bd | 1.43e-04 | 16 | 21 | 2 | IPR006861 | |
| Domain | VWF_type-D | 1.43e-04 | 16 | 21 | 2 | IPR001846 | |
| Domain | VWD | 1.43e-04 | 16 | 21 | 2 | PF00094 | |
| Domain | Disintegrin_CS | 1.43e-04 | 16 | 21 | 2 | IPR018358 | |
| Domain | ADAM_CR | 1.82e-04 | 18 | 21 | 2 | PF08516 | |
| Domain | - | 2.26e-04 | 20 | 21 | 2 | 4.10.70.10 | |
| Domain | DISIN | 2.50e-04 | 21 | 21 | 2 | SM00050 | |
| Domain | Disintegrin | 2.50e-04 | 21 | 21 | 2 | PF00200 | |
| Domain | ADAM_Cys-rich | 4.16e-04 | 27 | 21 | 2 | IPR006586 | |
| Domain | ACR | 4.16e-04 | 27 | 21 | 2 | SM00608 | |
| Domain | VWC | 4.47e-04 | 28 | 21 | 2 | PF00093 | |
| Domain | VWFC_1 | 7.41e-04 | 36 | 21 | 2 | PS01208 | |
| Domain | VWC | 8.26e-04 | 38 | 21 | 2 | SM00214 | |
| Domain | VWFC_2 | 8.26e-04 | 38 | 21 | 2 | PS50184 | |
| Domain | Peptidase_M12B_N | 8.70e-04 | 39 | 21 | 2 | IPR002870 | |
| Domain | Pep_M12B_propep | 8.70e-04 | 39 | 21 | 2 | PF01562 | |
| Domain | DISINTEGRIN_1 | 9.15e-04 | 40 | 21 | 2 | PS00427 | |
| Domain | ADAM_MEPRO | 9.15e-04 | 40 | 21 | 2 | PS50215 | |
| Domain | DISINTEGRIN_2 | 9.15e-04 | 40 | 21 | 2 | PS50214 | |
| Domain | Reprolysin | 9.15e-04 | 40 | 21 | 2 | PF01421 | |
| Domain | Peptidase_M12B | 9.15e-04 | 40 | 21 | 2 | IPR001590 | |
| Domain | Disintegrin_dom | 9.62e-04 | 41 | 21 | 2 | IPR001762 | |
| Domain | VWF_dom | 1.01e-03 | 42 | 21 | 2 | IPR001007 | |
| Domain | EGF_3 | 2.21e-03 | 235 | 21 | 3 | PS50026 | |
| Domain | EGF_1 | 2.79e-03 | 255 | 21 | 3 | PS00022 | |
| Domain | EGF_2 | 3.11e-03 | 265 | 21 | 3 | PS01186 | |
| Domain | MetalloPept_cat_dom | 3.70e-03 | 81 | 21 | 2 | IPR024079 | |
| Domain | - | 3.70e-03 | 81 | 21 | 2 | 3.40.390.10 | |
| Domain | Leu-rich_rpt_typical-subtyp | 1.67e-02 | 177 | 21 | 2 | IPR003591 | |
| Domain | LRR_TYP | 1.67e-02 | 177 | 21 | 2 | SM00369 | |
| Domain | LRR | 2.12e-02 | 201 | 21 | 2 | PS51450 | |
| Domain | LRR_1 | 2.48e-02 | 219 | 21 | 2 | PF00560 | |
| Pathway | REACTOME_RAS_PROCESSING | 2.19e-09 | 45 | 18 | 5 | MM15671 | |
| Pathway | REACTOME_DEUBIQUITINATION | 5.99e-07 | 262 | 18 | 6 | MM15286 | |
| Pathway | REACTOME_DEUBIQUITINATION | 1.30e-06 | 299 | 18 | 6 | M27574 | |
| Pathway | REACTOME_MAPK_FAMILY_SIGNALING_CASCADES | 1.86e-06 | 318 | 18 | 6 | MM15278 | |
| Pathway | REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES | 3.22e-06 | 191 | 18 | 5 | MM15289 | |
| Pathway | REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES | 6.57e-06 | 221 | 18 | 5 | M27578 | |
| Pathway | PID_INTEGRIN_A9B1_PATHWAY | 4.54e-04 | 25 | 18 | 2 | M118 | |
| Pathway | REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION | 1.52e-03 | 1475 | 18 | 7 | M19806 | |
| Pubmed | High Dub3 expression in mouse ESCs couples the G1/S checkpoint to pluripotency. | 1.56e-14 | 10 | 22 | 5 | 24207026 | |
| Pubmed | 4.91e-14 | 12 | 22 | 5 | 24695638 | ||
| Pubmed | ES cell neural differentiation reveals a substantial number of novel ESTs. | 1.24e-13 | 14 | 22 | 5 | 11793228 | |
| Pubmed | CDK4/6-dependent activation of DUB3 regulates cancer metastasis through SNAIL1. | 7.18e-13 | 19 | 22 | 5 | 28067227 | |
| Pubmed | Lymphocyte-specific murine deubiquitinating enzymes induced by cytokines. | 1.26e-12 | 21 | 22 | 5 | 12447969 | |
| Pubmed | DUB-2A, a new member of the DUB subfamily of hematopoietic deubiquitinating enzymes. | 1.26e-12 | 21 | 22 | 5 | 11468161 | |
| Pubmed | 1.26e-12 | 21 | 22 | 5 | 18980247 | ||
| Pubmed | The murine DUB-1 gene is specifically induced by the betac subunit of interleukin-3 receptor. | 1.26e-12 | 21 | 22 | 5 | 8756639 | |
| Pubmed | DUB-1, a deubiquitinating enzyme with growth-suppressing activity. | 1.26e-12 | 21 | 22 | 5 | 8622927 | |
| Pubmed | 1.26e-12 | 21 | 22 | 5 | 14583620 | ||
| Pubmed | 1.62e-12 | 22 | 22 | 5 | 9154835 | ||
| Pubmed | DUB-2 is a member of a novel family of cytokine-inducible deubiquitinating enzymes. | 2.62e-12 | 24 | 22 | 5 | 8995226 | |
| Pubmed | 3.27e-12 | 25 | 22 | 5 | 21115691 | ||
| Pubmed | 4.05e-12 | 26 | 22 | 5 | 35816173 | ||
| Pubmed | 7.31e-12 | 29 | 22 | 5 | 32527007 | ||
| Pubmed | 1.46e-11 | 33 | 22 | 5 | 20228807 | ||
| Pubmed | USP17 regulates Ras activation and cell proliferation by blocking RCE1 activity. | 1.71e-11 | 34 | 22 | 5 | 19188362 | |
| Pubmed | Polyclonal and monoclonal antibodies specific for USP17, a proapoptotic deubiquitinating enzyme. | 1.71e-11 | 34 | 22 | 5 | 20715989 | |
| Pubmed | 1.71e-11 | 34 | 22 | 5 | 17109758 | ||
| Pubmed | 1.71e-11 | 34 | 22 | 5 | 11941478 | ||
| Pubmed | Human megasatellite DNA RS447: copy-number polymorphisms and interspecies conservation. | 1.71e-11 | 34 | 22 | 5 | 9806828 | |
| Pubmed | The ubiquitin-specific protease 17 is involved in virus-triggered type I IFN signaling. | 1.71e-11 | 34 | 22 | 5 | 20368735 | |
| Pubmed | The DUB/USP17 deubiquitinating enzymes, a multigene family within a tandemly repeated sequence. | 1.71e-11 | 34 | 22 | 5 | 15780755 | |
| Pubmed | 1.71e-11 | 34 | 22 | 5 | 20388806 | ||
| Pubmed | DUB-3, a cytokine-inducible deubiquitinating enzyme that blocks proliferation. | 1.71e-11 | 34 | 22 | 5 | 14699124 | |
| Pubmed | 1.71e-11 | 34 | 22 | 5 | 20403174 | ||
| Pubmed | 1.71e-11 | 34 | 22 | 5 | 10936051 | ||
| Pubmed | 1.71e-11 | 34 | 22 | 5 | 21448158 | ||
| Pubmed | Lys-63-specific deubiquitination of SDS3 by USP17 regulates HDAC activity. | 1.99e-11 | 35 | 22 | 5 | 21239494 | |
| Pubmed | Cytokine-regulated protein degradation by the ubiquitination system. | 1.99e-11 | 35 | 22 | 5 | 16611142 | |
| Pubmed | 2.31e-11 | 36 | 22 | 5 | 20147298 | ||
| Pubmed | Ubiquitin hydrolase Dub3 promotes oncogenic transformation by stabilizing Cdc25A. | 2.67e-11 | 37 | 22 | 5 | 20228808 | |
| Pubmed | DUX is a non-essential synchronizer of zygotic genome activation. | 1.29e-10 | 50 | 22 | 5 | 31806660 | |
| Pubmed | 1.54e-09 | 81 | 22 | 5 | 12838346 | ||
| Pubmed | 2.29e-08 | 48 | 22 | 4 | 16421571 | ||
| Pubmed | 2.97e-06 | 674 | 22 | 6 | 37196079 | ||
| Pubmed | 1.37e-05 | 9 | 22 | 2 | 12122015 | ||
| Pubmed | Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c. | 4.99e-04 | 248 | 22 | 3 | 24006456 | |
| Interaction | LCE5A interactions | 7.92e-05 | 90 | 19 | 3 | int:LCE5A | |
| Interaction | ADAM23 interactions | 1.00e-04 | 16 | 19 | 2 | int:ADAM23 | |
| Interaction | ADAM2 interactions | 1.14e-04 | 17 | 19 | 2 | int:ADAM2 | |
| Interaction | ADAM28 interactions | 1.28e-04 | 18 | 19 | 2 | int:ADAM28 | |
| Interaction | POPDC2 interactions | 2.11e-04 | 23 | 19 | 2 | int:POPDC2 | |
| Interaction | HOXA1 interactions | 3.01e-04 | 356 | 19 | 4 | int:HOXA1 | |
| Interaction | SLC15A2 interactions | 3.61e-04 | 30 | 19 | 2 | int:SLC15A2 | |
| Interaction | TMC4 interactions | 3.61e-04 | 30 | 19 | 2 | int:TMC4 | |
| Interaction | CPLX3 interactions | 3.85e-04 | 31 | 19 | 2 | int:CPLX3 | |
| Interaction | NMUR2 interactions | 3.85e-04 | 31 | 19 | 2 | int:NMUR2 | |
| Interaction | CACNB3 interactions | 4.11e-04 | 32 | 19 | 2 | int:CACNB3 | |
| Interaction | ADAM11 interactions | 4.64e-04 | 34 | 19 | 2 | int:ADAM11 | |
| Cytoband | 8p23.1 | 1.00e-08 | 154 | 22 | 5 | 8p23.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr8p23 | 8.09e-08 | 234 | 22 | 5 | chr8p23 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 9.59e-05 | 27 | 10 | 2 | 47 | |
| Coexpression | MADAN_DPPA4_TARGETS | 8.52e-09 | 86 | 22 | 5 | MM1312 | |
| Coexpression | GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_DN | 3.24e-08 | 112 | 22 | 5 | MM1095 | |
| Coexpression | GERY_CEBP_TARGETS | 1.93e-07 | 160 | 22 | 5 | MM1155 | |
| Coexpression | LU_EZH2_TARGETS_DN | 1.72e-05 | 400 | 22 | 5 | M2140 | |
| Coexpression | RICKMAN_TUMOR_DIFFERENTIATED_MODERATELY_VS_POORLY_UP | 1.53e-04 | 125 | 22 | 3 | M15672 | |
| Coexpression | GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP | 1.68e-04 | 647 | 22 | 5 | MM981 | |
| Coexpression | PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_UP | 1.87e-04 | 134 | 22 | 3 | M2185 | |
| Coexpression | SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP | 1.93e-04 | 352 | 22 | 4 | M17471 | |
| Coexpression | PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_UP | 2.00e-04 | 137 | 22 | 3 | MM886 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder mesenchyme_emap-3087_k-means-cluster#4_top-relative-expression-ranked_100 | 1.41e-06 | 30 | 16 | 3 | gudmap_developingLowerUrinaryTract_e13.5_bladder mesenchyme_100_k4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder mesenchyme_emap-3087_k-means-cluster#3_top-relative-expression-ranked_200 | 1.78e-05 | 69 | 16 | 3 | gudmap_developingLowerUrinaryTract_e13.5_bladder mesenchyme_200_k3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder mesenchyme_emap-3087_top-relative-expression-ranked_100 | 3.46e-05 | 86 | 16 | 3 | gudmap_developingLowerUrinaryTract_e13.5_bladder mesenchyme_100 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder mesenchyme_emap-3087_k-means-cluster#2_top-relative-expression-ranked_500 | 1.16e-04 | 129 | 16 | 3 | gudmap_developingLowerUrinaryTract_e13.5_bladder mesenchyme_500_k2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder mesenchyme_emap-3087_top-relative-expression-ranked_200 | 2.44e-04 | 166 | 16 | 3 | gudmap_developingLowerUrinaryTract_e13.5_bladder mesenchyme_200 | |
| ToppCell | droplet-Heart-4Chambers-18m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.23e-05 | 149 | 22 | 3 | 38890ddde0979977c8350f01497f1245ab51641a | |
| ToppCell | normal_Lung-Fibroblasts-Myofibroblasts|Fibroblasts / Location, Cell class and cell subclass | 6.96e-05 | 164 | 22 | 3 | 9b4a6007abae992db871d9f6f731d5af724de30d | |
| ToppCell | droplet-Spleen-SPLEEN-30m-Lymphocytic-NK_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.09e-05 | 165 | 22 | 3 | e24621c8d4dbafb407033d832fe9337f13feae34 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell-Mast_cells-Mast_cells_L.1.4.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.21e-05 | 166 | 22 | 3 | a42268a02a89fc97272e45c4cbe21acf04b7428c | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.61e-05 | 169 | 22 | 3 | c0824a93674e2bff0f09b2d2fab5bab016a2e379 | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.74e-05 | 170 | 22 | 3 | 50c6c571591aa4b218caefe5778c570c809f567e | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.74e-05 | 170 | 22 | 3 | 8fe32dcf924d5f6665f7febbc9647d96b1e96f06 | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.74e-05 | 170 | 22 | 3 | 3232db50b1a40f861e981a1b9c9073b81af9f832 | |
| ToppCell | Endothelial-A-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 8.01e-05 | 172 | 22 | 3 | a3201773a25832e92dd113fad165f1ecd37f5e91 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_vein-D231|Adult / Lineage, Cell type, age group and donor | 8.29e-05 | 174 | 22 | 3 | 2dd647c4fdf99fd1f7b838efef01baf2cbc3446d | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_vein|Adult / Lineage, Cell type, age group and donor | 8.58e-05 | 176 | 22 | 3 | 043683c61c5d1a7f8a4666a612310246bd3d83a2 | |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-T_cells-MAIT_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.87e-05 | 178 | 22 | 3 | f52f837e948deb6a2d031325f49891bca8d375da | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5-Exc_L4-5_RORB_HNRNPA1P46|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.02e-05 | 179 | 22 | 3 | 53e700494d251ec5649b2dea5fc7d5aeeeed572b | |
| ToppCell | COPD-Myeloid-DC_Mature|World / Disease state, Lineage and Cell class | 9.32e-05 | 181 | 22 | 3 | 675603a401d92cf9fdcd44e211ec899fa86a0d49 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_osteo-stroma-osteoblast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 9.47e-05 | 182 | 22 | 3 | ba066ff9029cc052b76e2330ec168cb2e9b7e498 | |
| ToppCell | Control-Lymphoid-T_Regulatory|Lymphoid / Disease state, Lineage and Cell class | 9.94e-05 | 185 | 22 | 3 | e481cacda0b6b25f5f0062b962df9a442053ac30 | |
| ToppCell | IPF-Myeloid-DC_Mature|World / Disease state, Lineage and Cell class | 1.01e-04 | 186 | 22 | 3 | d0d3953d9b199e0e792990b8551efb993393fe7e | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_artery|Adult / Lineage, Cell type, age group and donor | 1.01e-04 | 186 | 22 | 3 | 2d1c4ea2e401db89971582ee54618a8b0c81b8ac | |
| ToppCell | Control-Myeloid-DC_Mature|Control / Disease state, Lineage and Cell class | 1.03e-04 | 187 | 22 | 3 | 049780ca2a3e6adcd89dc2cf3095b5ad068b244a | |
| ToppCell | IPF-Myeloid-DC_Mature|IPF / Disease state, Lineage and Cell class | 1.03e-04 | 187 | 22 | 3 | 63e0304a0183b69aebb0d1a4640a506a0d6fb6e9 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-lymphatic_endothelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.04e-04 | 188 | 22 | 3 | 26915db8863f4115b46a81982e187322e21600fd | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.04e-04 | 188 | 22 | 3 | 3f76c0f912f8f023ea425be7f43593b3d7f967e3 | |
| ToppCell | COPD-Myeloid-DC_Mature|COPD / Disease state, Lineage and Cell class | 1.04e-04 | 188 | 22 | 3 | de93ccb53edb8599da9e312db0e3af604c21f673 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.04e-04 | 188 | 22 | 3 | 61ee7b152745164293d8a44ef91ee2393efbdca5 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Artery|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.06e-04 | 189 | 22 | 3 | b028466fcd36fdeceec752e55a24286a1cd62ae4 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Artery|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.06e-04 | 189 | 22 | 3 | c45734970036e6d28d5e3fe7c9458fae38a3f624 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L5-6_LAMP5_SFTA3_(Lamp5_Lhx6_2)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.08e-04 | 190 | 22 | 3 | 59720dfe9de1b980807644536c919d2a02ba69dd | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Artery|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.08e-04 | 190 | 22 | 3 | aed65d584ca0c25f6a8313c66b421a6618af82ea | |
| ToppCell | Control-Endothelial-VE_Venous|Endothelial / Disease state, Lineage and Cell class | 1.08e-04 | 190 | 22 | 3 | 4e30155203b4a8c5e496fcbe9348b67b98ebc625 | |
| ToppCell | COPD-Lymphoid-T_Regulatory|Lymphoid / Disease state, Lineage and Cell class | 1.09e-04 | 191 | 22 | 3 | 3ae18bc4e3dff49b5d5958da8ebc3f747274b69c | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Artery|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.09e-04 | 191 | 22 | 3 | 4b3d5157344dbfbf4fab518611cd9fa37fac7bd9 | |
| ToppCell | COPD-Myeloid-DC_Mature|Myeloid / Disease state, Lineage and Cell class | 1.11e-04 | 192 | 22 | 3 | baebd462f464e7d0e462d07a74bb5d685a9fc3b6 | |
| ToppCell | 367C-Myeloid-Dendritic-cDC_activated|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 1.11e-04 | 192 | 22 | 3 | e44e37e5aeba8628556020d05e1606b28e2faa4f | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-Activated_DCs|Myeloid_cells / Location, Cell class and cell subclass | 1.13e-04 | 193 | 22 | 3 | 024d30eb143d8278c0851c3a6c9426226fa3b480 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Gen_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.13e-04 | 193 | 22 | 3 | 6e1982d089a9de628e6006d23ff78a223fbd9f47 | |
| ToppCell | RV-10._Endothelium_II|World / Chamber and Cluster_Paper | 1.13e-04 | 193 | 22 | 3 | 2531266bc57339d4e2b22a88817008e32b8c1598 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_NK-natural_killer_cell-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.14e-04 | 194 | 22 | 3 | 0abca32c3547a45cebab0bd69c1f7a0002deaa80 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_NK-natural_killer_cell|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.14e-04 | 194 | 22 | 3 | a3a81638b55cb5fc08fe83c8b88f68d49b87e6cb | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_T_CD4/8-lo|GI_small-bowel / Manually curated celltypes from each tissue | 1.18e-04 | 196 | 22 | 3 | a54ec174461944229c98a0b48b4822a556191ccb | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4/8-lo-Trm_Tgd|GI_small-bowel / Manually curated celltypes from each tissue | 1.18e-04 | 196 | 22 | 3 | 5755ca4abcae3717894bbf7cbd49bca0a3a03067 | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_T_CD4/8-lo-Trm_Tgd|GI_small-bowel / Manually curated celltypes from each tissue | 1.18e-04 | 196 | 22 | 3 | 84cab9390794fe50203834b745722bf11c208ebd | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4/8-lo|GI_small-bowel / Manually curated celltypes from each tissue | 1.18e-04 | 196 | 22 | 3 | 181f3c1af565355b29f20ca6074147c313ca3477 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-B_(Myofibroblast)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.22e-04 | 198 | 22 | 3 | c55608633f66e3d434c5d81324efb07c5120d2c2 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-B_(Myofibroblast)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.22e-04 | 198 | 22 | 3 | 3e5459038fc6ed95f529eb4d1dc5113e16c19012 | |
| ToppCell | (5)_Fibroblasts-(5)_Fibroblast-B_(Myofibroblast)|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.22e-04 | 198 | 22 | 3 | 196257c4420ac801ed9fbb444f11718adb7560ae | |
| ToppCell | IPF-Endothelial-VE_Peribronchial|Endothelial / Disease state, Lineage and Cell class | 1.22e-04 | 198 | 22 | 3 | b8bd1ba268480f54451648e01631b615a3401144 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_2(LAMP5)-CA1-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.25e-04 | 200 | 22 | 3 | ca5401b76ab014080914bf78042d368cf318effa | |
| ToppCell | Neuronal-Inhibitory-iA-iA_2(LAMP5)-CA1|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.25e-04 | 200 | 22 | 3 | 40286010bd17cf9e34ecd5440953b072ebfae208 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-PAX6-TNFAIP8L3-L1-2|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.25e-04 | 200 | 22 | 3 | 978dfb3c1d5e1c3d778a089175c50b8b719626c0 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-PAX6-TNFAIP8L3|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.25e-04 | 200 | 22 | 3 | d28b27776c46054b01bdd1e0f1db7c5cd5a48b88 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_2(LAMP5)-CA1--L2-6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.25e-04 | 200 | 22 | 3 | 70c47d3bbe67d88c5b9dff99c33a603d25fa2ab0 | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Drd1-Excitatory_Neuron.Gad1Gad2.Drd1-Tpbg_(eccentric_SPN,_dSPN-like_markers)|Striatum / BrainAtlas - Mouse McCarroll V32 | 2.76e-04 | 50 | 22 | 2 | 9a54cd5a55ef53f7a8b43fe76c4e0e47b44b8c71 | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Drd1-Excitatory_Neuron.Gad1Gad2.Drd1-Tpbg_(eccentric_SPN,_dSPN-like_markers)-|Striatum / BrainAtlas - Mouse McCarroll V32 | 2.76e-04 | 50 | 22 | 2 | cd5e2a8f4fa4a31d0c7a74d5826485e42b3908f7 | |
| ToppCell | Posterior_cortex-Macroglia-ASTROCYTE-Gja1-Astrocyte.Gja1.Sparc_(Sparc)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 3.97e-04 | 60 | 22 | 2 | 746a1ac6e666d1d53a4bea8f103642f2fa42e725 | |
| ToppCell | Posterior_cortex-Macroglia-ASTROCYTE-Gja1-Astrocyte.Gja1.Sparc_(Sparc)--|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 3.97e-04 | 60 | 22 | 2 | f54674b9995680c7f201cf1142e7f9327960f42f | |
| ToppCell | Posterior_cortex-Macroglia-ASTROCYTE-Gja1-Astrocyte.Gja1.Sparc_(Sparc)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 3.97e-04 | 60 | 22 | 2 | 66542df5eb7080a879b02c306a7ccbd9f67bf54d | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW19-Neuronal-GABAergic_neurons|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 8.52e-04 | 88 | 22 | 2 | 5582fd7bac60c690ecd1f2aff1d446ccb69f79b9 | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_Mucinous-6|TCGA-Stomach / Sample_Type by Project: Shred V9 | 1.03e-03 | 97 | 22 | 2 | 489f5e12eb67b1850f1f2d7d4b229df1f4ceefe3 | |
| ToppCell | TCGA-Brain-Recurrent_Tumor-Low_Grade_Glioma-Oligoastrocytoma-3|TCGA-Brain / Sample_Type by Project: Shred V9 | 1.19e-03 | 104 | 22 | 2 | 1360c9fcb9a68b385aa28dabd0715e71c4867a5b | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.55e-03 | 119 | 22 | 2 | c3f1223356e7f245a460ea5568a223e34e458dc1 | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-NK-ILC-T_NK-ILC|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.73e-03 | 126 | 22 | 2 | e33957cf1541733b06de9f9e7b2801b3d8ae831d | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Undifferentiated_Pleomorphic_Sarcoma-7|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 1.76e-03 | 127 | 22 | 2 | c4809d8502f460370f824719d69b13b400a2b202 | |
| ToppCell | PND01-03-samps-Mesenchymal-Myofibroblast-MyoFB-3|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 1.98e-03 | 135 | 22 | 2 | 5b13ff740d9f7d96274aebb6b389a80f6004adc7 | |
| ToppCell | E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal-Intermediate_Fibroblast|E16.5-samps / Age Group, Lineage, Cell class and subclass | 2.04e-03 | 137 | 22 | 2 | dd5364a1002650d21e0c83d8c701b5f7b09d1c19 | |
| ToppCell | T_cells-Treg_cells|T_cells / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 2.07e-03 | 138 | 22 | 2 | 35880e23ef317862891b54ac6a2265ca03b1d12a | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.13e-03 | 140 | 22 | 2 | 7ca49bd7ba9381e75c10f888775df17e5d46804d | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.13e-03 | 140 | 22 | 2 | 1a31bc33d5723b9bc528cc0047ca5f4c80531c7a | |
| ToppCell | Mild/Remission-B_naive-13|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.19e-03 | 142 | 22 | 2 | 49873a2d9b1ae4bdbf253d1c09bf8845cc0cc917 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Fibroblasts|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.32e-03 | 146 | 22 | 2 | 86cddd0e7f954547b7ffdccb0329cd5c4b725ac1 | |
| ToppCell | (02)_Cycling_Basal_(regeneration)-(2)_48hpi|(02)_Cycling_Basal_(regeneration) / shred by cell type and Timepoint | 2.38e-03 | 148 | 22 | 2 | a061a745c09254e063411b7d835d5597a0007e29 | |
| ToppCell | Cerebellum-Endothelial-ENDOTHELIAL_TIP|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 2.41e-03 | 149 | 22 | 2 | 3980fa4f1986a2f164a1826ea043fb71f1d756cd | |
| ToppCell | TCGA-Breast|World / Sample_Type by Project: Shred V9 | 2.44e-03 | 150 | 22 | 2 | 08686ba1acac5c58667bf62e2af84c691d6bbdfb | |
| ToppCell | E15.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.57e-03 | 154 | 22 | 2 | e65e4636646164610f33f7bbac0d879a3ea55986 | |
| ToppCell | IIH-Treg-CD4_Treg|IIH / Condition, Cell_class and T cell subcluster | 2.57e-03 | 154 | 22 | 2 | d2211a892654b92decb208969040920f7ae8ba1e | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.57e-03 | 154 | 22 | 2 | 37765512dfae557b9f6eb30a29463b93682a4404 | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.60e-03 | 155 | 22 | 2 | c58a5fb8d853f12204e961d633e83452eb12a659 | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.60e-03 | 155 | 22 | 2 | 9cb8c42c2e451b2d4dcd7154a4b1bfd21bbb7ea8 | |
| ToppCell | facs-Marrow-B-cells-18m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.60e-03 | 155 | 22 | 2 | 7a16df1a40c7255c24dfb9a921b62871554c7b6d | |
| ToppCell | facs-Marrow-B-cells-18m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.60e-03 | 155 | 22 | 2 | f51a12556ca0a3416a6cf0687f908fb4e752fb2f | |
| ToppCell | TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Tall_Cell-1|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 2.64e-03 | 156 | 22 | 2 | 45a05c7a45a3ec8551818ab67f18b3b9553934c1 | |
| ToppCell | 368C-Lymphocytic-NK_cells-NK_cell_A|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.67e-03 | 157 | 22 | 2 | 542944030cd9b3f3559e64f9f6598694d74003c0 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-lymphocytic-T_lymphocytic-mature_NK_T_cell|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.67e-03 | 157 | 22 | 2 | 3aa12913410925d577205cb6f1f5ae6bea20d93f | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Fibroblasts-Pericyte_2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.70e-03 | 158 | 22 | 2 | 7f5426585d0d299d2b48e5fcb349950feffdef33 | |
| ToppCell | metastatic_Brain-Fibroblasts-Myofibroblasts|Fibroblasts / Location, Cell class and cell subclass | 2.70e-03 | 158 | 22 | 2 | ab05f6d7968ccd6d3826cd71b763dbedc83822c3 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.74e-03 | 159 | 22 | 2 | 5ca96db4281abb5f646150ccf36adc66ab201c78 | |
| ToppCell | facs-Lung-Endomucin-24m-Lymphocytic-Natural_Killer_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.74e-03 | 159 | 22 | 2 | 7619d0d49738dd08daf01b42664691a5323aa793 | |
| ToppCell | facs-Lung-Endomucin-24m-Lymphocytic-mature_NK_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.74e-03 | 159 | 22 | 2 | 4000ed0d3b7d488722bcd0042fa2ff4405aaab82 | |
| ToppCell | ICU-NoSEP-Lymphocyte-T_NK-gdT|ICU-NoSEP / Disease, Lineage and Cell Type | 2.77e-03 | 160 | 22 | 2 | 2798c5bd971407f27dd4d3a4831d63d9c88003c3 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Pygm_C1ql1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.80e-03 | 161 | 22 | 2 | 3b5d7a3dab479c6959a428f3954dedd989900276 | |
| ToppCell | Children_(3_yrs)-Immune-dendritic_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.80e-03 | 161 | 22 | 2 | cd41abb7ae659d3d314281783a0aaad562b26037 | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_B|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.80e-03 | 161 | 22 | 2 | f7dc1e3326ab22f2eb1e94b632469a0682a3289c | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.80e-03 | 161 | 22 | 2 | 1b805f77790aeb8a71b08bfac2fe2eed7343258f | |
| ToppCell | Club-club-13|World / Class top | 2.84e-03 | 162 | 22 | 2 | 7d18f05a65ac715e62d610df9cc4a26539340dee | |
| ToppCell | Brain_organoid-organoid_Velasco_nature-3_mon-Neuronal-Cajal-Retzius|3_mon / Sample Type, Dataset, Time_group, and Cell type. | 2.84e-03 | 162 | 22 | 2 | 1f589a763f3fd4e1e612809ef3903879d47dc1d8 | |
| ToppCell | droplet-Lung-nan-18m-Lymphocytic-Natural_Killer|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.84e-03 | 162 | 22 | 2 | 66069146e2666d13c594bd76247893354a697c5d | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-glomerular_mesenchymal_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.84e-03 | 162 | 22 | 2 | 82e782096f89cd03d1fdf599ba727d6f23e35e2d | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.84e-03 | 162 | 22 | 2 | 6bed33b17b59812646dc6a29c1d87413bad86c11 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.84e-03 | 162 | 22 | 2 | 502ed67f6a572f10ac6e22948a1747d8214eb974 | |
| ToppCell | droplet-Kidney-nan-24m-Lymphocytic-NK_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.87e-03 | 163 | 22 | 2 | d18fee517e0daed51f89703f94f218567c83cb03 | |
| ToppCell | droplet-Kidney-nan-24m-Lymphocytic-CD45____NK_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.87e-03 | 163 | 22 | 2 | f4a6e28ad3c1fcbf62ed9b2bf09f65d2ab0b31d1 | |
| Computational | Adhesion molecules. | 1.75e-04 | 141 | 9 | 3 | MODULE_122 | |
| Computational | Neighborhood of EGFR | 3.05e-04 | 32 | 9 | 2 | GNF2_EGFR | |
| Computational | Neighborhood of TIMP2 | 6.33e-04 | 46 | 9 | 2 | GNF2_TIMP2 | |
| Computational | Neighborhood of KISS1 | 7.18e-04 | 49 | 9 | 2 | GNF2_KISS1 | |
| Disease | primary ovarian insufficiency (implicated_via_orthology) | 1.47e-10 | 46 | 21 | 5 | DOID:5426 (implicated_via_orthology) | |
| Disease | congenital heart disease (implicated_via_orthology) | 1.19e-09 | 69 | 21 | 5 | DOID:1682 (implicated_via_orthology) | |
| Disease | amino acid measurement | 1.21e-03 | 678 | 21 | 4 | EFO_0005134 | |
| Disease | mosquito bite reaction itch intensity measurement | 3.77e-03 | 129 | 21 | 2 | EFO_0008377 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PCCENCLFMSKERMC | 431 | Q99965 | |
| CMNRCCNATTCTLKP | 446 | O43184 | |
| CACSLKAMIMCQGCG | 1506 | Q8IXJ9 | |
| PIQMCCPSCNKMIVS | 91 | Q99732 | |
| RMCCPGMKVSCQLQV | 1576 | Q38SD2 | |
| IMTMQRPFRCTCCCF | 186 | Q9NRQ2 | |
| PCIMCVCLNKEVTCK | 66 | Q8N8U9 | |
| PQSLTVVCMCACMCV | 121 | Q96N68 | |
| VVCMCACMCVCVHVC | 126 | Q96N68 | |
| CMCVLVCMCACACMR | 146 | Q96N68 | |
| NPVARCIMCCFKCCL | 531 | Q53GD3 | |
| AQELPGRMTKMQCCC | 376 | P35556 | |
| GRMTKMQCCCEPGRC | 381 | P35556 | |
| ICCCCTMLTAISMSA | 226 | Q9UHW9 | |
| METAMCVCCPCCTWQ | 1 | Q8IWZ5 | |
| CCCCKKRSQAVLMQM | 561 | Q8TF66 | |
| ICMKCTAVLCCRMAP | 781 | Q8NB49 | |
| TCQRPKCCMLCTMQA | 116 | A6NCW0 | |
| TCQRPKCCMLCTMQA | 116 | A6NCW7 | |
| CPSCRCERMEACMLN | 2571 | P04275 | |
| TCQRPKCCMLCTMQA | 116 | Q7RTZ2 | |
| CCCCSVQKRQMRTQI | 16 | P42681 | |
| TCQRPKCCMLCTMQA | 116 | P0C7I0 | |
| QCYCRPMWCLTCMGK | 311 | A0AVI4 | |
| TCQRPKCCMLCTMQA | 116 | Q6R6M4 |